Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 14.11.2024
Marker Therapeutics Мультипликаторы 2011-2024 | MRKR
Мультипликаторы по годам Marker Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.2 | -3.1 | -5.7 | -0.7 | -3.2 | -11.8 | -0.8 | -0.1 | -0.4 | -1.8 | -3.6 |
P/S |
1.8 | 5.9 | 192.8 | 573.1 | 512.5 | - | - | - | - | - | - | - |
EPS |
-3.6 | -5.5 | -0.6 | -0.5 | -7.8 | -1.2 | -0.4 | -9.3 | -2 | -4.9 | -9.4 | -0.0 |
EV (Enterprise Value) |
19.2 млн | -10.9 млн | 86.9 млн | 80.5 млн | 46.6 млн | 31.5 млн | 22.8 млн | 47.4 млн | 3.89 млн | 11.1 млн | 16.2 млн | 10.9 млн |
EBITDA per Share |
-3.25 | -4.88 | -0.593 | -0.488 | -7.76 | -1.27 | -1.2 | -1.68 | -2.62 | -28.1 | -102 | -68.8 |
EV/EBITDA |
0.5 | -2.5 | -3.5 | -0.3 | -2.5 | -2.6 | -3.2 | -0.8 | -2.1 | -2.1 | -3.1 | |
PEG |
-0.0 | -0.0 | 0.11 | -0.06 | 0.0 | 0.01 | -0.12 | -0.01 | -0.0 | -0.01 | 0.01 | -0.05 |
P/B |
0.8 | 0.2 | 3.3 | 2.8 | 1.8 | 9.6 | 4.7 | -1.2 | -2.7 | -0.3 | -1.9 | -2.1 |
P/CF |
-0.6 | -0.3 | -3.1 | -6.5 | -7.2 | -4.2 | -4.4 | -6.0 | -1.3 | -3.3 | -6.7 | -5.6 |
ROE % |
-152.70 | -95.21 | -104.98 | -48.60 | -249.34 | -300.21 | -39.70 | 159.48 | 3017.00 | 63.10 | 103.38 | 58.63 |
ROA % |
-86.95 | -61.46 | -62.93 | -46.22 | -238.09 | -211.99 | -31.00 | -512.63 | -13759.58 | -7182.15 | -5621.18 | -596.38 |
ROCE % |
-112.41 | -71.47 | -73.66 | -50.78 | -249.70 | -313.82 | -133.58 | 28.83 | 329.31 | 30.39 | 96.67 | 76.20 |
Current Ratio |
2.3 | 2.8 | 3.8 | 22.8 | 22.1 | 3.4 | 4.6 | 0.2 | 0.2 | 0.0 | 0.0 | 0.1 |
DSO |
- | - | 782.4 | 96.2 | 191.7 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Marker Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.26 | -0.25 | -0.27 | - | -0.34 | 0.29 | -0.57 | - | -0.83 | -1.11 | -1.19 | - | -0.15 | -0.13 | -0.16 | - | -0.16 | -0.14 | -0.14 | - | -0.12 | -0.12 | -0.12 | - | -0.32 | -0.41 | -0.3 | - | -0.39 | -0.22 | -0.29 | - | -0.29 | 1.01 | -0.81 | - | 7.04 | -1.8 | -0.03 | - | -0.09 | 0.05 | -3.89 | - | -0.76 | -0.87 | -0.55 | - | -0.01 | -0.04 | -0.01 | - | -0.02 | -0.01 | -0.03 |
EBITDA per Share |
- | - | - | - | - | - | -0.4 | - | -0.46 | -0.49 | -1.11 | - | -0.1 | -0.12 | -0.15 | - | -0.15 | -0.13 | -0.14 | - | -0.12 | -0.13 | -0.12 | - | -0.32 | -0.39 | -0.3 | - | -0.39 | -0.28 | -0.29 | - | -0.37 | -0.41 | -0.3 | - | -0.43 | -0.03 | -0.04 | - | - | - | - | - | -0.25 | -0.67 | -1.12 | - | -0.01 | -0.05 | -0.01 | - | -0.02 | -0.02 | -0.02 |
ROE % |
-91.73 | -78.59 | -42.78 | -35.85 | -66.46 | -79.23 | -125.43 | -91.36 | -115.13 | -108.29 | -92.55 | -53.13 | -80.09 | -83.27 | -89.22 | -73.87 | -86.25 | -71.68 | -61.12 | -37.08 | -44.48 | -39.49 | -34.97 | -20.89 | -129.84 | -231.40 | -275.04 | -226.86 | -260.86 | -185.92 | -37.56 | -14.21 | -147.65 | -247.08 | -61.77 | 151.75 | 304.91 | 591.51 | 236.00 | 2981.68 | 3005.14 | 2875.44 | 2958.98 | 1004.35 | 1004.35 | 1022.98 | 1055.14 | 94.08 | 76.39 | 100.79 | 70.39 | 72.72 | 24.40 | 11.69 | 36.63 |
ROA % |
-72.22 | -66.37 | -36.13 | -21.62 | -38.45 | -39.98 | -69.11 | -52.53 | -69.81 | -70.26 | -66.14 | -40.77 | -56.93 | -55.81 | -56.16 | -44.28 | -56.06 | -51.67 | -49.79 | -35.27 | -42.33 | -37.61 | -33.34 | -19.95 | -96.88 | -166.76 | -195.56 | -160.19 | -186.74 | -136.36 | -24.39 | -11.09 | 417.83 | 873.30 | 752.26 | 337.68 | 337.68 | -45.62 | -13281.30 | -26471.37 | -27842.43 | -15977.81 | -61920.13 | -93255.69 | -93255.69 | -48853.03 | -51763.74 | -6506.51 | -3843.96 | -4092.12 | -1300.27 | -739.63 | -248.16 | -118.86 | -372.60 |
ROCE % |
- | - | -18.95 | -37.91 | -57.44 | -58.02 | -71.58 | -54.05 | -69.78 | -65.98 | -67.00 | -40.74 | -59.55 | -62.63 | -64.26 | -51.97 | -64.71 | -58.65 | -55.67 | -38.69 | -46.16 | -40.87 | -35.51 | -20.73 | -129.79 | -231.38 | -288.93 | -240.55 | -284.56 | -219.51 | -193.30 | -111.58 | -103.45 | -51.30 | -6.76 | 18.28 | 18.28 | 10.14 | 4.81 | - | 3.57 | 7.15 | 14.85 | 23.99 | 37.18 | 46.79 | 91.02 | 76.24 | 102.39 | 115.36 | 83.69 | 78.22 | 26.15 | 20.27 | 31.80 |
Current Ratio |
3.1 | 5.9 | 6.1 | 5.6 | 7.0 | 7.5 | 2.3 | 2.3 | 2.2 | 2.1 | 2.9 | 2.8 | 3.7 | 4.7 | 5.6 | 2.5 | 2.5 | 2.5 | 2.5 | 20.4 | 20.4 | 20.4 | 20.4 | 22.2 | 22.2 | 22.2 | 22.2 | 3.4 | 3.4 | 3.4 | 3.4 | 4.6 | 4.6 | 4.6 | 4.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.1 | 0.2 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.7 | - | - | - | - | - | - | - | 47.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.7 | - | - | - | - | - | - | - | 47.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.7 | - | - | - | - | - | - | - | 47.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD